Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2021 Jul 14;32(9):1909. doi: 10.1007/s00198-021-06031-0

Retraction Note to: Comment on an article: “Osteoporosis in the age of COVID-19 patients”

O Ć Ibrahimagić 1, A Vujadinović 2, Z Ercegović 3, S Kunić 4,, Dž Smajlović 1, Z Dostović 1
PMCID: PMC8277984  PMID: 34259885

Retraction Note to: Osteoporosis International (2021) 32:783–784

10.1007/s00198-020-05607-6

The Editors-in Chief have retracted this Letter to the Editor. The Letter presents the same hypothesis relating to B-vitamins in the treatment of COVID-19 as a previous Letter to the Editor by the same author group in another journal [1]. The Editors-in-Chief therefore consider this Letter to be redundant. The authors disagree with this retraction.

Footnotes

The online version of the original article can be found at 10.1007/s00198-020-05607-6

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Reference

  • 1.Omer Ć. Ibrahimagić, Zlatko Ercegović, Aleksandar Vujadinović & Suljo Kunić. Medications in COVID-19 patients: summarizing the current literature from an orthopaedic perspective. International Orthopaedics (SICOT) 2020;44:2811–2812. doi: 10.1007/s00264-020-04782-9. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Osteoporosis International are provided here courtesy of Nature Publishing Group

RESOURCES